摘要 |
<p>The present invention relates to the use of HC gp-39 to prevent inflammatory diseases. More specifically, HC gp-39 or fragments thereof can be used to modulate the reactivity of lymphocytes which are reactive to antigens other than HC gp-39 but which are present in the same tissue as where HC gp-39 is being expressed.</p> |